Changes Clinical Practice: Patients with high-risk myelodysplastic syndrome (MDS) should be offered azacitidine as a standard of care.是什么意思_Changes Clinical Practice: Patients with high-risk myelodysplastic syndrome (MDS) should be offered azacitidine as a standard of care.在線(xiàn)翻譯_英語(yǔ)_讀音_用法_例句